Presentation and treatment of a rare case of metaplastic breast cancer: A case report

被引:0
作者
Torabi, Hossein [1 ]
Rodd, Marjan [1 ]
Shirini, Kasra [2 ,3 ]
机构
[1] Guilan Univ Med Sci, Poursina Med & Educ Ctr, Dept Gen Surg, Rasht, Gilan, Iran
[2] Iran Univ Med Sci, Dept Gen Surg, Tehran, Iran
[3] Iran Univ Med Sci, Dept Gen Surg, Hemmat Highway Net Milad Tower, Tehran 14665354, Iran
来源
SAGE OPEN MEDICAL CASE REPORTS | 2023年 / 11卷
关键词
Metaplastic breast cancer; breast carcinosarcoma; modified radical mastectomy; CARCINOSARCOMA; CARCINOMA; OUTCOMES; TUMORS;
D O I
10.1177/2050313X231205715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast carcinosarcoma, also known as metaplastic breast cancer, is one of the rarest types of breast cancer. It is an aggressive and poor prognostic breast cancer compared to triple-negative breast cancer. Due to the lack of specific and prescribed treatment, it could threaten patients' lives, especially women worldwide. There are various diagnostic methods, such as multiple imaging and pathology methods, to diagnose breast cancers. Still, considering the common appearance characteristic of this type of breast cancer with other types, histopathology is the most definitive way. There is no standard neoadjuvant or adjuvant chemotherapy for this rare type of breast cancer. In this article, we reported the case of a 62-year-old female with a final diagnosis of metaplastic breast carcinoma and her surgical and medical treatment method.
引用
收藏
页数:5
相关论文
共 30 条
[1]   Metaplastic Breast Cancer: Clinical Overview and Molecular Aberrations for Potential Targeted Therapy [J].
Abouharb, Sausan ;
Moulder, Stacy .
CURRENT ONCOLOGY REPORTS, 2015, 17 (03) :1-7
[2]   Intermammary breast cancer: A rare case of cancer with origin of breast cells in an unusual location [J].
Aghajanzadeh, Manouchehr ;
Torabi, Hossein ;
Najafi, Behrouz ;
Talebi, Pedram ;
Shirini, Kasra .
SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
[3]   Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy [J].
Al-Hilli, Zahraa ;
Choong, Grace ;
Keeney, Michael G. ;
Visscher, Daniel W. ;
Ingle, James N. ;
Goetz, Matthew P. ;
Jakub, James W. .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (03) :709-716
[4]  
Al-Share M., 2022, J Cancer Tumor Int, V12, P30
[5]  
Azamjah Nasrindokht, 2019, Asian Pac J Cancer Prev, V20, P2015, DOI 10.31557/APJCP.2019.20.7.2015
[6]   Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era [J].
Chen, I. C. ;
Lin, C. H. ;
Huang, C. S. ;
Lien, H. C. ;
Hsu, Chiun ;
Kuo, W. H. ;
Lu, Y. S. ;
Cheng, A. L. .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) :345-351
[7]  
Esses Kristi M, 2009, Cases J, V2, P15, DOI 10.1186/1757-1626-2-15
[8]  
Haque W., 2022, Clin Breast Cancer, V22
[9]   Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis [J].
He, Xuexin ;
Ji, Jiali ;
Dong, Rongrong ;
Liu, Hong ;
Dai, Xiaolan ;
Wang, Chongjian ;
Esteva, Francisco J. ;
Yeung, Sai-Ching Jim .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (02) :329-341
[10]   Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society [J].
Husband, JE ;
Schwartz, LH ;
Spencer, J ;
Ollivier, L ;
King, DM ;
Johnson, R ;
Reznek, R .
BRITISH JOURNAL OF CANCER, 2004, 90 (12) :2256-2260